National Institutes of Health — Office of the NIH Director
Jun 2025 – Present
Program Analyst
via Guidehouse · Bethesda, MD
- Authored a publication with the FDA Commissioner, the FDA CDER Director, and the NIH Deputy Director on alternatives to animal testing in preclinical research, in NEJM AI.
- Co-led development of the $5M AI and Biomedical Foundation Model Challenge.
- Led portfolio analysis for the Bio Genesis Mission, a $1.2B initiative from NIH's Chief AI Office.
- Co-authored and supported development of the NIH AI Strategic Plan (2026–2029).
- Built a multi-agent dashboard for the multimodal-AI award program using LLMs and MCP servers, cutting award-management time by roughly 50% in six months.
- Deployed a portfolio analysis agent now serving six NIH Institutes and Centers, used for 15+ analyses for NIH leadership.
- Delivered three portfolio analyses under compressed deadlines for congressional House Appropriations, analyzing 1,900+ grants with custom agentic AI pipelines.
Human Chemical Company
Dec 2025 – Jul 2026
AI Solutions Strategy Consultant
Chapel Hill, NC
- Developed tools to assess pharmacokinetic properties of chemicals for an agentic AI startup.
National Institute of Environmental Health Sciences
Jun 2024 – May 2025
Intern
Division of Translational Toxicology, NICEATM · Morrisville, NC
Supervisor: Dr. Nicole Kleinstreuer, Director of NICEATM
- Presented computational modeling work on skin sensitization, developmental toxicity, and acute and chronic toxicity at seven conferences; received 14 research awards and a best paper of the year award at the SOT Annual Meeting.
- Published 10 projects aimed at refining and replacing animal use in toxicity testing with machine learning.
- Collaborated with industry partners to model complex mixtures and review best practices for deep learning in medicinal chemistry.
UNC Molecular Modeling Lab
May 2023 – May 2025
Machine Learning Intern
Chapel Hill, NC
Supervisor: Dr. Alexander Tropsha
- Led AI and machine-learning implementation for five toxicology projects on developmental toxicity, skin sensitization, and liver toxicity.
- Contributed to over $1.8M in awarded funding for species-specific toxicity concordance analysis and mechanism-based modeling.
- Applied QSAR best practices across eight endpoints — data curation, performance benchmarking, context of use, model validation, and 2D similarity.